Large-scale testing (Phase 3)Study completedNCT00397345What this trial is testingTroVax Renal Immunotherapy Survival TrialWho this might be right forClear Cell Renal Carcinoma Oxford BioMedica 733
Testing effectiveness (Phase 2)Looking for participantsNCT07571551What this trial is testingPerioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell RCC Jinling Hospital, China 75
Testing effectiveness (Phase 2)Looking for participantsNCT06940518What this trial is testingPhase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell CarcinomaWho this might be right forIvonescimabClear Cell Renal Carcinoma M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT00788125What this trial is testingDasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more City of Hope Medical Center 7
Testing effectiveness (Phase 2)UnknownNCT01069770What this trial is testingNeoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)Who this might be right forClear Cell Renal Cell CarcinomaMetastasis Korean Urological Oncology Society 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT05808608What this trial is testingAK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell CarcinomaWho this might be right forRenal Cell CarcinomaFirst-line TreatmentNon Clear Cell Renal Cell Carcinoma+1 more Hao Zeng 37
Testing effectiveness (Phase 2)Looking for participantsNCT06211790What this trial is testingProteomic Guided First-line Precision Treatment of Renal Clear Cell CarcinomaWho this might be right forKidney CancerRenal Cell CarcinomaRenal Clear Cell Carcinoma Fudan University 66
Testing effectiveness (Phase 2)Study completedNCT00866320What this trial is testingSorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or BevacizumabWho this might be right forKidney Cancer Case Comprehensive Cancer Center 49
Early research (Phase 1)Study completedNCT04518046What this trial is testingStudy of Sitravatinib, Nivolumab and Ipilimumab in Advanced or Metastatic Clear-Cell Renal Cell Carcinoma or Other Solid MalignanciesWho this might be right forClear-Cell Renal Cell Carcinoma Mirati Therapeutics Inc. 22
Testing effectiveness (Phase 2)Study completedNCT01354431What this trial is testingBMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)Who this might be right forRenal Cell Carcinoma Bristol-Myers Squibb 168
Not applicableWithdrawnNCT01977586What this trial is testingFunctional Imaging in the Assessment of mRCC Response to SunitinibWho this might be right forMetastatic Renal Cell Carcinoma Imperial College Healthcare NHS Trust
Early research (Phase 1)Study completedNCT02315066What this trial is testingStudy Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566Who this might be right forNeoplasms Pfizer 174
Testing effectiveness (Phase 2)Study completedNCT02700568What this trial is testingAxitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic FactorsWho this might be right forCarcinoma, Renal CellClear Cell Renal Cell Carcinoma Kidney Cancer Research Bureau 21
Not applicableWithdrawnNCT00499291What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsWho this might be right forCancer Eastern Cooperative Oncology Group
Early research (Phase 1)Ended earlyNCT02595918What this trial is testingNivolumab in Treating Patients With High-Risk Kidney Cancer Before SurgeryWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Renal Cell CarcinomaStage I Renal Cell Cancer AJCC v6 and v7+3 more National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT05012371What this trial is testingLenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell CancerWho this might be right forAdvanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Ended earlyNCT01582009What this trial is testingPanobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib TosylateWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage III Renal Cell Cancer+1 more Roswell Park Cancer Institute 26
Early research (Phase 1)Study completedNCT00258687What this trial is testingVaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV MelanomaWho this might be right forSarcoma, Clear CellSarcoma, Alveolar Soft PartRenal Cell Carcinoma+1 more Dana-Farber Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT01499121What this trial is testingStudy of Efficacy and Safety of Sunitinib Given on an Individualized ScheduleWho this might be right forClear Cell, Metastatic Renal Cell Carcinoma Sunnybrook Health Sciences Centre 117
Early research (Phase 1)Looking for participantsNCT07062549What this trial is testingStudy of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal CellWho this might be right forRenal Cell Carcinoma (Kidney Cancer) Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6